# ColonScopeX: Leveraging Explainable Expert Systems with Multimodal Data for Improved Early Diagnosis of Colorectal Cancer

arXiv: https://arxiv.org/abs/2504.08824 · HTML: https://mlsanity.com/paper/2504.08824/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 7 of its 28 references that are in the map.
- First posted on arXiv 9 Apr 2025.

## Builds on (most cited first, 7 of 7)

- ["Why Should I Trust You?": Explaining the Predictions of Any Classifier](https://mlsanity.com/paper/1602.04938/) (2016)
- [Deep Multi-modal Fusion of Image and Non-image Data in Disease Diagnosis and Prognosis: A Review](https://mlsanity.com/paper/2203.15588/) (2022)
- [GLIME: General, Stable and Local LIME Explanation](https://mlsanity.com/paper/2311.15722/) (2023)
- [Challenges for machine learning in clinical translation of big data imaging studies](https://mlsanity.com/paper/2107.05630/) (2021)
- [A Multi-modal Fusion Framework Based on Multi-task Correlation Learning for Cancer Prognosis Prediction](https://mlsanity.com/paper/2201.10353/) (2022)
- [Shaping Up SHAP: Enhancing Stability through Layer-Wise Neighbor Selection](https://mlsanity.com/paper/2312.12115/) (2023)
- [SHAP@k:Efficient and Probably Approximately Correct (PAC) Identification of Top-k Features](https://mlsanity.com/paper/2307.04850/) (2023)

## Abstract (arXiv)

Colorectal cancer (CRC) ranks as the second leading cause of cancer-related deaths and the third most prevalent malignant tumour worldwide. Early detection of CRC remains problematic due to its non-specific and often embarrassing symptoms, which patients frequently overlook or hesitate to report to clinicians. Crucially, the stage at which CRC is diagnosed significantly impacts survivability, with a survival rate of 80-95% for Stage I and a stark decline to 10% for Stage IV. Unfortunately, in the UK, only 14.4% of cases are diagnosed at the earliest stage (Stage I). In this study, we propose ColonScopeX, a machine learning framework utilizing explainable AI (XAI) methodologies to enhance the early detection of CRC and pre-cancerous lesions. Our approach employs a multimodal model that integrates signals from blood sample measurements, processed using the Savitzky-Golay algorithm for fingerprint smoothing, alongside comprehensive patient metadata, including medication history, comorbidities, age, weight, and BMI. By leveraging XAI techniques, we aim to render the model's decision-making process transparent and interpretable, thereby fostering greater trust and understanding in its predictions. The proposed framework could be utilised as a triage tool or a screening tool of the general population. This research highlights the potential of combining diverse patient data sources and explainable machine learning to tackle critical challenges in medical diagnostics.
